Major investments in basic science have created an opportunity for significant progress in
clinical medicine. Researchers have discovered hundreds of genes that harbor variations
contributing to human illness, identified genetic variability in patients' responses to dozens of
treatments, and begun to target the molecular causes of some diseases. In addition,
scientists are developing and using diagnostic tests based on genetics or other molecular
mechanisms to better predict patients' responses to targeted therapy. The challenge is to …